DrugPatentWatch Database Preview

Tavaborole - Generic Drug Details

What are the generic sources for tavaborole and what is the scope of tavaborole patent protection?
Tavaborole is the generic ingredient in one branded drug marketed by Anacor Pharms Inc and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Tavaborole has sixty-nine patent family members in twenty countries.

There are five drug master file entries for tavaborole. One supplier is listed for this compound.

Summary for tavaborole

International Patents:	69
US Patents:	5
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	5
Suppliers / Packagers:	1
Bulk Api Vendors:	49
Patent Applications:	77
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for tavaborole
DailyMed Link:	tavaborole at DailyMed

Pharmacology for tavaborole

Ingredient-type	Boron Compounds
Drug Class	Oxaborole Antifungal
Mechanism of Action	Protein Synthesis Inhibitors

Synonyms for tavaborole

1,3-dihydro-5-fluoro-1-hydroxy-2,1-benzoxaborole
174671-46-6
2,1-Benzoxaborole, 5-fluoro-1,3-dihydro-1-hydroxy-
3338AH
5-fluoro-1-hydroxy-3H-2,1-benzoxaborole
5-Fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole
5-fluoro-1,3-dihydro-2,1-benzoxaborol-1-ol
5-fluoro-2,1-benzoxaborol-1(3H)-ol
5-Fluoro-3H-benzo[c][1,2)oxaborol-1-ol
5-fluoro-3H-benzo[c][1,2]oxaborol-1-ol
5-FLUOROBENZO[C][1,2]OXABOROL-1(3H)-OL
AK163946
AKOS006303927
AN 2690
AN-2690
AN-2690(Tavaborole)
AN-2690)
AN2690
BDBM50370987
C7H6BFO2
CHEBI:77942
CHEMBL443052
CS-1058
CTK8H2675
D05VGL
D10169
DB09041
DTXSID00169888
EX-A1086
FT-0697827
Fungal leucyl-tRNA synthetase inhibitor (onychomycosis), Anacor Pharmaceuticals/Schering-Plough
Fungal leucyl-tRNA synthetase inhibitor (onychomycosis), Merck & Co/Anacor
HSDB 8342
HY-10980
K124A4EUQ3
KB-74687
Kerydin
Kerydin (TN)
KS-00000SPV
LFQDNHWZDQTITF-UHFFFAOYSA-N
MB08883
MFCD10699483
MolPort-027-845-281
NCGC00264110-01
SCH-900340
SCHEMBL500016
ST24044751
Tavaborole (USAN)
Tavaborole [USAN:INN]
Topical antifungal (onychomycosis), Merck & Co
Trichophyton-targeting antifungal (onychomycosis), Anacor Pharmaceuticals/Schering-Plough
Trichophyton-targeting antifungal (onychomycosis), Merck & Co
UNII-K124A4EUQ3
W-5454
X3699
Z1739256284
ZINC169990691

US Patents and Regulatory Information for tavaborole

+ Get email alerts for changes to this table

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Anacor Pharms Inc	KERYDIN	tavaborole	SOLUTION;TOPICAL	204427-001	Jul 7, 2014		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Anacor Pharms Inc	KERYDIN	tavaborole	SOLUTION;TOPICAL	204427-001	Jul 7, 2014		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Anacor Pharms Inc	KERYDIN	tavaborole	SOLUTION;TOPICAL	204427-001	Jul 7, 2014		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Anacor Pharms Inc	KERYDIN	tavaborole	SOLUTION;TOPICAL	204427-001	Jul 7, 2014		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

or, see our see our flat-rate plans

Non-Orange Book US Patents for tavaborole

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
8,115,026	Boron-containing small molecules	➤ Sign Up
7,767,657	Boron-containing small molecules	➤ Sign Up
8,889,656	Boron-containing small molecules	➤ Sign Up
9,353,133	Boron-containing small molecules	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration